For example, constitutive activation of PI3K/AKT signaling increases intracellular cholesterol levels through SREBP-1 activation, resulting in de novo cholesterol biosynthesis and LDL receptor (LDLR) expression, thereby enhancing exogenous cholesterol import in prostate cancer (Guo et al., 2011). This evidence concerns the gene LDLR and prostate carcinoma.